Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that leads to memory loss, confusion, and changes in behavior, significantly impacting daily life.
Early Alzheimer's Disease: NIO752 Study
We are investigating a new medication for people with early Alzheimer's disease to assess its safety and how it works in the body. This study aims to gather important information about the treatment's effects.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Of Eastern Finland
1102 : Institute of Clinical Medicine, Brain Research Unit
Kuopio, Finland
Clinical Research Services Turku CRST Oy
1101 : Clinical Research Unit (Phase I)
Turku, Finland
Centre Hospitalier Universitaire De Toulouse
3000 : Département de Neurologie
Blagnac, France
Sponsor: Novartis Pharma AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.